Cancer Research Institute held its annual Through the Kitchen benefit party yesterday evening and raised $1.4 million to fund six promising postdoctoral fellows over three years.

A second CAR T cell immunotherapy targeting the CD19 receptor was approved by the FDA for patients with relapsed or refractory large B cell lymphoma.